In a prospective cross-sectional study, researchers investigated an involvement of the visual pathway in patients with chronic inflammatory demyelinating polyneuropathy.
Researchers sought to investigate the association between lower retinal nerve fiber layer thickness, a marker of neurodegeneration, with clinically relevant depressive symptoms and depressive symptoms over time.
In a cohort study, researchers sought to examine the association of visual impairment with the future risk of developing Parkinson disease.
Researchers examined whether treatment with CD20 inhibitors resulted in worse COVID-19 outcomes among patients with immune-mediated diseases.
Researchers analyzed the temporal trend in racial and ethnic differences in the use of intravenous thrombolysis after stroke between 2009 and 2018 in a representative sample of adults in the US.
Researchers sought to compare the frequency, racial differences, neurologic phenotype, and outcome of attacks that required ventilator support in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Researchers assessed whether zolpidem (priming) is required for partial reinforcement or whether intermittent dosing with placebos can be effective for acute and extended treatment for patients with chronic insomnia.
Researchers assessed the humoral and cell-mediated immune responses to SARS-CoV-2 mRNA-based vaccines in patients with a history of receiving CD20-targeted B-cell-depleting therapy.
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there’s no substantial evidence that they directly increase the risk for vascular events.
The primary efficacy endpoint was the change in the mean number of migraine days per month during the 12-week study period.
